- Home
- HTCO vs OCGN Comparison
HTCO vs OCGN Comparison
Compare HTCO & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCO
- OCGN
- Stock Information
- Founded
- HTCO N/A
- OCGN 2013
- Country
- HTCO Singapore
- OCGN United States
- Employees
- HTCO N/A
- OCGN N/A
- Industry
- HTCO
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTCO
- OCGN Health Care
- Exchange
- HTCO NYSE
- OCGN Nasdaq
- Market Cap
- HTCO 210.6M
- OCGN 246.8M
- IPO Year
- HTCO N/A
- OCGN N/A
- Fundamental
- Price
- HTCO $2.30
- OCGN $0.77
- Analyst Decision
- HTCO
- OCGN Strong Buy
- Analyst Count
- HTCO 0
- OCGN 3
- Target Price
- HTCO N/A
- OCGN $5.67
- AVG Volume (30 Days)
- HTCO 151.6K
- OCGN 5.1M
- Earning Date
- HTCO 02-15-2025
- OCGN 11-08-2024
- Dividend Yield
- HTCO N/A
- OCGN N/A
- EPS Growth
- HTCO N/A
- OCGN N/A
- EPS
- HTCO N/A
- OCGN N/A
- Revenue
- HTCO $80,567,672.00
- OCGN $4,700,000.00
- Revenue This Year
- HTCO N/A
- OCGN N/A
- Revenue Next Year
- HTCO N/A
- OCGN N/A
- P/E Ratio
- HTCO N/A
- OCGN N/A
- Revenue Growth
- HTCO N/A
- OCGN N/A
- 52 Week Low
- HTCO $0.21
- OCGN $0.39
- 52 Week High
- HTCO $2.78
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- HTCO N/A
- OCGN 33.97
- Support Level
- HTCO N/A
- OCGN $0.74
- Resistance Level
- HTCO N/A
- OCGN $0.89
- Average True Range (ATR)
- HTCO 0.00
- OCGN 0.06
- MACD
- HTCO 0.00
- OCGN -0.01
- Stochastic Oscillator
- HTCO 0.00
- OCGN 19.40
About HTCO CARAVELLE INTERNATIONAL GROUP
Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").